VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q54222617  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241121000317.0
008     241121nneanz||abbn n and d
035 ‎‡a  (WKP)Q54222617‏
024 ‎‡a  0000-0002-9951-7979‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q54222617‏
100 0 ‎‡a  Luis I Fernández-Salazar‏ ‎‡9  ast‏ ‎‡9  es‏ ‎‡9  sl‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Luis I Fernández-Salazar‏ ‎‡c  researcher‏ ‎‡9  en‏
400 0 ‎‡a  Luis I Fernández-Salazar‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's Abdominal mass, multiple lymphadenopathies, and polyposis‏
670 ‎‡a  Author's Accuracy of Urea Breath Test Performed Immediately After Emergency Endoscopy in Peptic Ulcer Bleeding‏
670 ‎‡a  Author's Acute esophageal necrosis resolved in 72 hours.‏
670 ‎‡a  Author's Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry‏
670 ‎‡a  Author's Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp.‏
670 ‎‡a  Author's [Amebiasis and intestinal inflammatory disease]‏
670 ‎‡a  Author's An unexpected finding of cat scratch colon in a screening colonoscopy‏
670 ‎‡a  Author's [Annular pancreas: a potentially overlooked congenital pancreatic anomaly]‏
670 ‎‡a  Author's Another multiple gastric anisakiasis case‏
670 ‎‡a  Author's [Antral vascular ectasia: etiopathogenic, clinical, and therapeutic aspects]‏
670 ‎‡a  Author's Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis‏
670 ‎‡a  Author's Are Worries and Concerns Information Side Effects?‏
670 ‎‡a  Author's Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients.‏
670 ‎‡a  Author's Atmospheric pressure does not influence acute diverticular disease‏
670 ‎‡a  Author's [Autoimmune pancreatitis: response to corticoids test]‏
670 ‎‡a  Author's Cat scratch esophagus‏
670 ‎‡a  Author's [Changes in iron metabolism in chronic hepatitis C]‏
670 ‎‡a  Author's Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal Colon‏
670 ‎‡a  Author's Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study‏
670 ‎‡a  Author's Clinical status, quality of life, and work productivity in Crohn's disease patients after one year of treatment with adalimumab.‏
670 ‎‡a  Author's Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment.‏
670 ‎‡a  Author's [Colonic polyps: dysplasia predictive factors]‏
670 ‎‡a  Author's Corrigendum: Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.‏
670 ‎‡a  Author's Crohn's disease diagnosis during adalimumab treatment.‏
670 ‎‡a  Author's Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group.‏
670 ‎‡a  Author's Detection of specific IgA antibodies against a novel deamidated 8-Mer gliadin peptide in blood plasma samples from celiac patients‏
670 ‎‡a  Author's [Diagnostic problems in adult celiac disease]‏
670 ‎‡a  Author's Differential diagnosis and management of histologic eosinophilic colitis‏
670 ‎‡a  Author's Doubts and similarities between Crohn's disease and Henoch-Schönlein purpura‏
670 ‎‡a  Author's Duodenal lymphogram as a complementary tool in the diagnosis of celiac disease in adults‏
670 ‎‡a  Author's Early Thiopurine Treatment Is Probably Beneficial but Time From Diagnosis Must Be Evaluated.‏
670 ‎‡a  Author's Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry‏
670 ‎‡a  Author's [Efficacy of thalidomide in digestive bleeding caused by angiodysplasias]‏
670 ‎‡a  Author's [Elevated transaminase levels in adult celiac disease]‏
670 ‎‡a  Author's [Endoscopic appearance of the duodenal bulb in adult celiac disease]‏
670 ‎‡a  Author's [Endoscopy in celiac disease]‏
670 ‎‡a  Author's Eosinophilic esophagitis after an episode of herpetic esophagitis‏
670 ‎‡a  Author's EUS-guided choledochoduodenostomy with lumen-apposing metal stent after failed rendezvous in synchronous malignant biliary and gastric outlet obstruction (with video)‏
670 ‎‡a  Author's Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-life‏
670 ‎‡a  Author's Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.‏
670 ‎‡a  Author's Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.‏
670 ‎‡a  Author's Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients‏
670 ‎‡a  Author's Frequency, predictors, and consequences of maintenance infliximab therapy intensification in ulcerative colitis‏
670 ‎‡a  Author's Gastric metastasis from renal cell carcinoma‏
670 ‎‡a  Author's [Gastrointestinal stromal tumors (GISTs): clinical aspects]‏
670 ‎‡a  Author's H. pylori-negative duodenal ulcer prevalence and causes in 774 patients‏
670 ‎‡a  Author's [Hamartomatous polyp of the hypopharynx]‏
670 ‎‡a  Author's Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.‏
670 ‎‡a  Author's High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD‏
670 ‎‡a  Author's Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.‏
670 ‎‡a  Author's Human colon-derived soluble factors modulate gut microbiota composition.‏
670 ‎‡a  Author's [Hydatidic cyst fistulized to colon]‏
670 ‎‡a  Author's IFN beta 1b induced celiac disease‏
670 ‎‡a  Author's IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate‏
670 ‎‡a  Author's IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: differences between DQ2 positive and negative patients‏
670 ‎‡a  Author's Immune thrombocytopenic purpura associated with inactive ulcerative colitis in chronic treatment with adalimumab‏
670 ‎‡a  Author's Impact of the endoscopist's experience on the negative predictive value of capsule endoscopy.‏
670 ‎‡a  Author's [Incidence and pathogenesis of acute pancreatitis in Crohn disease]‏
670 ‎‡a  Author's Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study‏
670 ‎‡a  Author's Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum‏
670 ‎‡a  Author's Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).‏
670 ‎‡a  Author's Interleukin 18 maintains a long-standing inflammation in coeliac disease patients‏
670 ‎‡a  Author's Iron overload and genotype 3 are associated with liver steatosis in chronic hepatitis C.‏
670 ‎‡a  Author's Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides‏
670 ‎‡a  Author's Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.‏
670 ‎‡a  Author's [Lymphadenomegaly or papillar process?]‏
670 ‎‡a  Author's Meckel's diverticulum and enteroliths complicating Crohn's disease‏
670 ‎‡a  Author's [Meckel's diverticulum and gastrointestinal stromal tumor: an unusual association]‏
670 ‎‡a  Author's Natural history of irritable bowel syndrome.‏
670 ‎‡a  Author's Neuroendocrine tumor associate with inflammatory bowel disease: two cases report‏
670 ‎‡a  Author's No increase in Epstein-Barr virus viral load in a group of 30 asymptomatic patients with Crohn's disease.‏
670 ‎‡a  Author's NOD2/CARD15 gene mutations in patients with inflammatory bowel disease in Valladolid‏
670 ‎‡a  Author's Nodular colonic lesion in a nephrectomized patient‏
670 ‎‡a  Author's [Non-alcoholic fatty liver disease, serum iron indexes and iron concentration in the liver].‏
670 ‎‡a  Author's Octreotide and angiodysplasia‏
670 ‎‡a  Author's Percutaneous liver biopsy: patients' point of view‏
670 ‎‡a  Author's [Pericholangitis and primary sclerosing cholangitis]‏
670 ‎‡a  Author's Pitavastatin: other statin to be used and monitored‏
670 ‎‡a  Author's Predictable bad evolution of an acute pancreatitis‏
670 ‎‡a  Author's Prevalence and factors associated with poor sleep quality in inflammatory bowel disease outpatients‏
670 ‎‡a  Author's [Primary prophylaxis of post-polylipectomy bleeding with clips]‏
670 ‎‡a  Author's Radiation enteritidis diagnosed by wireless capsule endoscopy‏
670 ‎‡a  Author's Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa‏
670 ‎‡a  Author's Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) y de la Confederación de Asociaciones de Enfermedad de Crohn y Colitis Ulcerosa (ACCU) para el manejo de los aspectos psicológicos en la enfermedad in‏
670 ‎‡a  Author's [Relapsing colitis cystica profunda]‏
670 ‎‡a  Author's Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients‏
670 ‎‡a  Author's [Respiratory insufficiency, vomiting and diarrhea in a Down's syndrome patient]‏
670 ‎‡a  Author's Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease‏
670 ‎‡a  Author's [Solid liver mass. Studies with nuclear medicine]‏
670 ‎‡a  Author's Spontaneous bacterial peritonitis due to Gemella morbillorum in a patient under chronic treatment with norfloxacin‏
670 ‎‡a  Author's [Study of gastronitestinal transit times with capsule endoscopy]‏
670 ‎‡a  Author's [Submucosal tumor at the bottom of the cecum]‏
670 ‎‡a  Author's [Synchronic MALT lymphoma and carcinoid tumor of the ileum]‏
670 ‎‡a  Author's The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire.‏
670 ‎‡a  Author's The simultaneous high expression of Vα24, IFN-γ and FoxP3 characterizes the liver of children with type I autoimmune hepatitis.‏
670 ‎‡a  Author's The utility of faecal calprotectin to predict post-operative recurrence in Crohńs disease‏
670 ‎‡a  Author's Treating Helicobacter pylori infection in the face of growing antibiotic resistance‏
670 ‎‡a  Author's [Triple pylorus or double antroduodenal fistula]‏
670 ‎‡a  Author's Tuberculosis, one more consideration in the differential diagnosis of a pancreatic mass‏
670 ‎‡a  Author's [Ulcerative colitis and autoimmune hemolytic anemia]‏
670 ‎‡a  Author's Using the internet to evaluate the opinion of patients with inflammatory bowel disease with regard to the available information.‏
670 ‎‡a  Author's Villous atrophy persistence in celiac disease despite following a gluten-free diet must be clarified‏
670 ‎‡a  Author's [Visceral leishmaniasis diagnosed by duodenal biopsy]‏
909 ‎‡a  (orcid) 0000000299517979‏ ‎‡9  1‏
919 ‎‡a  differentialdiagnosisandmanagementofhistologiceosinophiliccolitis‏ ‎‡A  Differential diagnosis and management of histologic eosinophilic colitis‏ ‎‡9  1‏
919 ‎‡a  duodenallymphogramasacomplementarytoolinthediagnosisofceliacdiseaseinadults‏ ‎‡A  Duodenal lymphogram as a complementary tool in the diagnosis of celiac disease in adults‏ ‎‡9  1‏
919 ‎‡a  earlythiopurinetreatmentisprobablybeneficialbuttimefromdiagnosismustbeevaluated‏ ‎‡A  Early Thiopurine Treatment Is Probably Beneficial but Time From Diagnosis Must Be Evaluated.‏ ‎‡9  1‏
919 ‎‡a  effectivenessandsafetyofthesequentialuseofa2and3antitnfagentinpatientswithinflammatoryboweldiseaseresultsfromtheeneidaregistry‏ ‎‡A  Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry‏ ‎‡9  1‏
919 ‎‡a  efficacyofthalidomideindigestivebleedingcausedbyangiodysplasias‏ ‎‡A  [Efficacy of thalidomide in digestive bleeding caused by angiodysplasias]‏ ‎‡9  1‏
919 ‎‡a  elevatedtransaminaselevelsinadultceliacdisease‏ ‎‡A  [Elevated transaminase levels in adult celiac disease]‏ ‎‡9  1‏
919 ‎‡a  endoscopicappearanceoftheduodenalbulbinadultceliacdisease‏ ‎‡A  [Endoscopic appearance of the duodenal bulb in adult celiac disease]‏ ‎‡9  1‏
919 ‎‡a  endoscopyinceliacdisease‏ ‎‡A  [Endoscopy in celiac disease]‏ ‎‡9  1‏
919 ‎‡a  eosinophilicesophagitisafteranepisodeofherpeticesophagitis‏ ‎‡A  Eosinophilic esophagitis after an episode of herpetic esophagitis‏ ‎‡9  1‏
919 ‎‡a  eusguidedcholedochoduodenostomywithlumenapposingmetalstentafterfailedrendezvousinsynchronousmalignantbiliaryandgastricoutletobstructionwithvideo‏ ‎‡A  EUS-guided choledochoduodenostomy with lumen-apposing metal stent after failed rendezvous in synchronous malignant biliary and gastric outlet obstruction (with video)‏ ‎‡9  1‏
919 ‎‡a  evennonexpertsidentifynondysplasticlesionsininflammatoryboweldiseaseviachromoendoscopyresultsofascreeningprograminreallife‏ ‎‡A  Even non-experts identify non-dysplastic lesions in inflammatory bowel disease via chromoendoscopy: results of a screening program in real-life‏ ‎‡9  1‏
919 ‎‡a  evolutionafterantitnfdiscontinuationinpatientswithinflammatoryboweldiseaseamulticenterlongtermfollowupstudy‏ ‎‡A  Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.‏ ‎‡9  1‏
919 ‎‡a  extracoloniccancerininflammatoryboweldiseasedatafromthegeteccueneidaregistry‏ ‎‡A  Extracolonic Cancer in Inflammatory Bowel Disease: Data from the GETECCU Eneida Registry.‏ ‎‡9  1‏
919 ‎‡a  fecalglutenpeptidesreveallimitationsofserologicaltestsandfoodquestionnairesformonitoringglutenfreedietinceliacdiseasepatients‏ ‎‡A  Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients‏ ‎‡9  1‏
919 ‎‡a  frequencypredictorsandconsequencesofmaintenanceinfliximabtherapyintensificationinulcerativecolitis‏ ‎‡A  Frequency, predictors, and consequences of maintenance infliximab therapy intensification in ulcerative colitis‏ ‎‡9  1‏
919 ‎‡a  gastricmetastasisfromrenalcellcarcinoma‏ ‎‡A  Gastric metastasis from renal cell carcinoma‏ ‎‡9  1‏
919 ‎‡a  gastrointestinalstromaltumorsgistsclinicalaspects‏ ‎‡A  [Gastrointestinal stromal tumors (GISTs): clinical aspects]‏ ‎‡9  1‏
919 ‎‡a  hpylorinegativeduodenalulcerprevalenceandcausesin774patients‏ ‎‡A  H. pylori-negative duodenal ulcer prevalence and causes in 774 patients‏ ‎‡9  1‏
919 ‎‡a  hamartomatouspolypofthehypopharynx‏ ‎‡A  [Hamartomatous polyp of the hypopharynx]‏ ‎‡9  1‏
919 ‎‡a  helicobacterpylori2linerescuetherapywithlevofloxacinandbismuthcontainingquadrupletherapyafterfailureofstandardtripleornonbismuthquadrupletreatments‏ ‎‡A  Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments.‏ ‎‡9  1‏
919 ‎‡a  highlevelsofproinflammatorycytokinesbutnotmarkersoftissueinjuryinunaffectedintestinalareasfrompatientswithibd‏ ‎‡A  High levels of proinflammatory cytokines, but not markers of tissue injury, in unaffected intestinal areas from patients with IBD‏ ‎‡9  1‏
919 ‎‡a  higherconstitutiveil15ralphaexpressionandloweril15responsethresholdincoeliacdiseasepatients‏ ‎‡A  Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.‏ ‎‡9  1‏
919 ‎‡a  humancolonderivedsolublefactorsmodulategutmicrobiotacomposition‏ ‎‡A  Human colon-derived soluble factors modulate gut microbiota composition.‏ ‎‡9  1‏
919 ‎‡a  hydatidiccystfistulizedtocolon‏ ‎‡A  [Hydatidic cyst fistulized to colon]‏ ‎‡9  1‏
919 ‎‡a  ifnbeta1binducedceliacdisease‏ ‎‡A  IFN beta 1b induced celiac disease‏ ‎‡9  1‏
919 ‎‡a  6promotesimmuneresponsesinhumanulcerativecolitisandinducesaskinhomingphenotypeinthedendriticcellsandtcellstheystimulate‏ ‎‡A  IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and Tcells they stimulate‏ ‎‡9  1‏
919 ‎‡a  il6il10andtgfb1genepolymorphismsincoeliacdiseasedifferencesbetweendq2positiveandnegativepatients‏ ‎‡A  IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: differences between DQ2 positive and negative patients‏ ‎‡9  1‏
919 ‎‡a  immunethrombocytopenicpurpuraassociatedwithinactiveulcerativecolitisinchronictreatmentwithadalimumab‏ ‎‡A  Immune thrombocytopenic purpura associated with inactive ulcerative colitis in chronic treatment with adalimumab‏ ‎‡9  1‏
919 ‎‡a  impactoftheendoscopistsexperienceonthenegativepredictivevalueofcapsuleendoscopy‏ ‎‡A  Impact of the endoscopist's experience on the negative predictive value of capsule endoscopy.‏ ‎‡9  1‏
919 ‎‡a  incidenceandpathogenesisofacutepancreatitisincrohndisease‏ ‎‡A  [Incidence and pathogenesis of acute pancreatitis in Crohn disease]‏ ‎‡9  1‏
919 ‎‡a  incidenceclinicalcharacteristicsandmanagementofpsoriasisinducedbyantitnftherapyinpatientswithinflammatoryboweldiseaseanationwidecohortstudy‏ ‎‡A  Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study‏ ‎‡9  1‏
919 ‎‡a  increasedintraepithelialvα24invariantnktcellsintheceliacduodenum‏ ‎‡A  Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum‏ ‎‡9  1‏
919 ‎‡a  infliximabinulcerativecolitisreallifeanalysisoffactorspredictingtreatmentdiscontinuationduetolackofresponseorcolectomyeciaacadcolitisandinfliximabstudy‏ ‎‡A  Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).‏ ‎‡9  1‏
919 ‎‡a  interleukin18maintainsalongstandinginflammationincoeliacdiseasepatients‏ ‎‡A  Interleukin 18 maintains a long-standing inflammation in coeliac disease patients‏ ‎‡9  1‏
919 ‎‡a  ironoverloadandgenotype3areassociatedwithliversteatosisinchronichepatitis100‏ ‎‡A  Iron overload and genotype 3 are associated with liver steatosis in chronic hepatitis C.‏ ‎‡9  1‏
919 ‎‡a  isgliadinreallysafefornoncoeliacindividualsproductionofinterleukin15inbiopsyculturefromnoncoeliacindividualschallengedwithgliadinpeptides‏ ‎‡A  Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides‏ ‎‡9  1‏
919 ‎‡a  longtermsafetyofinuteroexposuretoantitnfαdrugsforthetreatmentofinflammatoryboweldiseaseresultsfromthemulticentereuropeanteddystudy‏ ‎‡A  Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study.‏ ‎‡9  1‏
919 ‎‡a  lymphadenomegalyorpapillarprocess‏ ‎‡A  [Lymphadenomegaly or papillar process?]‏ ‎‡9  1‏
919 ‎‡a  meckelsdiverticulumandenterolithscomplicatingcrohnsdisease‏ ‎‡A  Meckel's diverticulum and enteroliths complicating Crohn's disease‏ ‎‡9  1‏
919 ‎‡a  meckelsdiverticulumandgastrointestinalstromaltumoranunusualassociation‏ ‎‡A  [Meckel's diverticulum and gastrointestinal stromal tumor: an unusual association]‏ ‎‡9  1‏
919 ‎‡a  naturalhistoryofirritablebowelsyndrome‏ ‎‡A  Natural history of irritable bowel syndrome.‏ ‎‡9  1‏
919 ‎‡a  neuroendocrinetumorassociatewithinflammatoryboweldisease2casesreport‏ ‎‡A  Neuroendocrine tumor associate with inflammatory bowel disease: two cases report‏ ‎‡9  1‏
919 ‎‡a  noincreaseinepsteinbarrvirusviralloadinagroupof30asymptomaticpatientswithcrohnsdisease‏ ‎‡A  No increase in Epstein-Barr virus viral load in a group of 30 asymptomatic patients with Crohn's disease.‏ ‎‡9  1‏
919 ‎‡a  nod2card15genemutationsinpatientswithinflammatoryboweldiseaseinvalladolid‏ ‎‡A  NOD2/CARD15 gene mutations in patients with inflammatory bowel disease in Valladolid‏ ‎‡9  1‏
919 ‎‡a  nodularcoloniclesioninanephrectomizedpatient‏ ‎‡A  Nodular colonic lesion in a nephrectomized patient‏ ‎‡9  1‏
919 ‎‡a  nonalcoholicfattyliverdiseaseserumironindexesandironconcentrationintheliver‏ ‎‡A  [Non-alcoholic fatty liver disease, serum iron indexes and iron concentration in the liver].‏ ‎‡9  1‏
919 ‎‡a  octreotideandangiodysplasia‏ ‎‡A  Octreotide and angiodysplasia‏ ‎‡9  1‏
919 ‎‡a  percutaneousliverbiopsypatientspointofview‏ ‎‡A  Percutaneous liver biopsy: patients' point of view‏ ‎‡9  1‏
919 ‎‡a  pericholangitisandprimarysclerosingcholangitis‏ ‎‡A  [Pericholangitis and primary sclerosing cholangitis]‏ ‎‡9  1‏
919 ‎‡a  pitavastatinotherstatintobeusedandmonitored‏ ‎‡A  Pitavastatin: other statin to be used and monitored‏ ‎‡9  1‏
919 ‎‡a  predictablebadevolutionofanacutepancreatitis‏ ‎‡A  Predictable bad evolution of an acute pancreatitis‏ ‎‡9  1‏
919 ‎‡a  prevalenceandfactorsassociatedwithpoorsleepqualityininflammatoryboweldiseaseoutpatients‏ ‎‡A  Prevalence and factors associated with poor sleep quality in inflammatory bowel disease outpatients‏ ‎‡9  1‏
919 ‎‡a  primaryprophylaxisofpostpolylipectomybleedingwithclips‏ ‎‡A  [Primary prophylaxis of post-polylipectomy bleeding with clips]‏ ‎‡9  1‏
919 ‎‡a  radiationenteritidisdiagnosedbywirelesscapsuleendoscopy‏ ‎‡A  Radiation enteritidis diagnosed by wireless capsule endoscopy‏ ‎‡9  1‏
919 ‎‡a  recomendacionesdelgrupoespanoldetrabajoenenfermedaddecrohnycolitisulcerosa‏ ‎‡A  Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa‏ ‎‡9  1‏
919 ‎‡a  recomendacionesdelgrupoespanoldetrabajoenenfermedaddecrohnycolitisulcerosageteccuydelaconfederaciondeasociacionesdeenfermedaddecrohnycolitisulcerosaaccuparaelmanejodelosaspectospsicologicosenlaenfermedadin‏ ‎‡A  Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) y de la Confederación de Asociaciones de Enfermedad de Crohn y Colitis Ulcerosa (ACCU) para el manejo de los aspectos psicológicos en la enfermedad in‏ ‎‡9  1‏
919 ‎‡a  relapsingcolitiscysticaprofunda‏ ‎‡A  [Relapsing colitis cystica profunda]‏ ‎‡9  1‏
919 ‎‡a  resourcesutilizationandcoststheyearbeforeandafterstartingtreatmentwithadalimumabincrohnsdiseasepatients‏ ‎‡A  Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients‏ ‎‡9  1‏
919 ‎‡a  respiratoryinsufficiencyvomitinganddiarrheainadownssyndromepatient‏ ‎‡A  [Respiratory insufficiency, vomiting and diarrhea in a Down's syndrome patient]‏ ‎‡9  1‏
919 ‎‡a  serialtuberculinskintestsimprovethedetectionoflatenttuberculosisinfectioninpatientswithinflammatoryboweldisease‏ ‎‡A  Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease‏ ‎‡9  1‏
919 ‎‡a  solidlivermassstudieswithnuclearmedicine‏ ‎‡A  [Solid liver mass. Studies with nuclear medicine]‏ ‎‡9  1‏
919 ‎‡a  spontaneousbacterialperitonitisduetogemellamorbilloruminapatientunderchronictreatmentwithnorfloxacin‏ ‎‡A  Spontaneous bacterial peritonitis due to Gemella morbillorum in a patient under chronic treatment with norfloxacin‏ ‎‡9  1‏
919 ‎‡a  studyofgastronitestinaltransittimeswithcapsuleendoscopy‏ ‎‡A  [Study of gastronitestinal transit times with capsule endoscopy]‏ ‎‡9  1‏
919 ‎‡a  submucosaltumoratthebottomofthececum‏ ‎‡A  [Submucosal tumor at the bottom of the cecum]‏ ‎‡9  1‏
919 ‎‡a  synchronicmaltlymphomaandcarcinoidtumoroftheileum‏ ‎‡A  [Synchronic MALT lymphoma and carcinoid tumor of the ileum]‏ ‎‡9  1‏
919 ‎‡a  concernsofspanishpatientswithinflammatoryboweldiseaseasmeasuredbytherfipcquestionnaire‏ ‎‡A  The concerns of Spanish patients with inflammatory bowel disease as measured by the RFIPC questionnaire.‏ ‎‡9  1‏
919 ‎‡a  simultaneoushighexpressionofvα24ifnγandfoxp3characterizestheliverofchildrenwithtype1autoimmunehepatitis‏ ‎‡A  The simultaneous high expression of Vα24, IFN-γ and FoxP3 characterizes the liver of children with type I autoimmune hepatitis.‏ ‎‡9  1‏
919 ‎‡a  utilityoffaecalcalprotectintopredictpostoperativerecurrenceincrohnsdisease‏ ‎‡A  The utility of faecal calprotectin to predict post-operative recurrence in Crohńs disease‏ ‎‡9  1‏
919 ‎‡a  treatinghelicobacterpyloriinfectioninthefaceofgrowingantibioticresistance‏ ‎‡A  Treating Helicobacter pylori infection in the face of growing antibiotic resistance‏ ‎‡9  1‏
919 ‎‡a  triplepylorusordoubleantroduodenalfistula‏ ‎‡A  [Triple pylorus or double antroduodenal fistula]‏ ‎‡9  1‏
919 ‎‡a  tuberculosis1moreconsiderationinthedifferentialdiagnosisofapancreaticmass‏ ‎‡A  Tuberculosis, one more consideration in the differential diagnosis of a pancreatic mass‏ ‎‡9  1‏
919 ‎‡a  ulcerativecolitisandautoimmunehemolyticanemia‏ ‎‡A  [Ulcerative colitis and autoimmune hemolytic anemia]‏ ‎‡9  1‏
919 ‎‡a  usingtheinternettoevaluatetheopinionofpatientswithinflammatoryboweldiseasewithregardtotheavailableinformation‏ ‎‡A  Using the internet to evaluate the opinion of patients with inflammatory bowel disease with regard to the available information.‏ ‎‡9  1‏
919 ‎‡a  villousatrophypersistenceinceliacdiseasedespitefollowingaglutenfreedietmustbeclarified‏ ‎‡A  Villous atrophy persistence in celiac disease despite following a gluten-free diet must be clarified‏ ‎‡9  1‏
919 ‎‡a  visceralleishmaniasisdiagnosedbyduodenalbiopsy‏ ‎‡A  [Visceral leishmaniasis diagnosed by duodenal biopsy]‏ ‎‡9  1‏
919 ‎‡a  doubtsandsimilaritiesbetweencrohnsdiseaseandhenochschonleinpurpura‏ ‎‡A  Doubts and similarities between Crohn's disease and Henoch-Schönlein purpura‏ ‎‡9  1‏
919 ‎‡a  diagnosticproblemsinadultceliacdisease‏ ‎‡A  [Diagnostic problems in adult celiac disease]‏ ‎‡9  1‏
919 ‎‡a  detectionofspecificigaantibodiesagainstanoveldeamidated8mergliadinpeptideinbloodplasmasamplesfromceliacpatients‏ ‎‡A  Detection of specific IgA antibodies against a novel deamidated 8-Mer gliadin peptide in blood plasma samples from celiac patients‏ ‎‡9  1‏
919 ‎‡a  currentconceptsonmicroscopiccolitisevidencebasedstatementsandrecommendationsofthespanishmicroscopiccolitisgroup‏ ‎‡A  Current concepts on microscopic colitis: evidence-based statements and recommendations of the Spanish Microscopic Colitis Group.‏ ‎‡9  1‏
919 ‎‡a  crohnsdiseasediagnosisduringadalimumabtreatment‏ ‎‡A  Crohn's disease diagnosis during adalimumab treatment.‏ ‎‡9  1‏
919 ‎‡a  corrigendumfecalglutenpeptidesreveallimitationsofserologicaltestsandfoodquestionnairesformonitoringglutenfreedietinceliacdiseasepatients‏ ‎‡A  Corrigendum: Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.‏ ‎‡9  1‏
919 ‎‡a  colonicpolypsdysplasiapredictivefactors‏ ‎‡A  [Colonic polyps: dysplasia predictive factors]‏ ‎‡9  1‏
919 ‎‡a  collagenouscolitisrequirementforhighdosebudesonideasmaintenancetreatment‏ ‎‡A  Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment.‏ ‎‡9  1‏
919 ‎‡a  clinicalstatusqualityoflifeandworkproductivityincrohnsdiseasepatientsafter1yearoftreatmentwithadalimumab‏ ‎‡A  Clinical status, quality of life, and work productivity in Crohn's disease patients after one year of treatment with adalimumab.‏ ‎‡9  1‏
919 ‎‡a  clinicalcharacteristicsassociatedmalignanciesandmanagementofprimarysclerosingcholangitisininflammatoryboweldiseasepatientsamulticentreretrospectivecohortstudy‏ ‎‡A  Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study‏ ‎‡9  1‏
919 ‎‡a  chemokine100100motifreceptor2mediatesdendriticcellrecruitmenttothehumancolonbutisnotresponsiblefordifferencesobservedindendriticcellsubsetsphenotypeandfunctionbetweentheproximalanddistalcolon‏ ‎‡A  Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal Colon‏ ‎‡9  1‏
919 ‎‡a  changesinironmetabolisminchronichepatitis100‏ ‎‡A  [Changes in iron metabolism in chronic hepatitis C]‏ ‎‡9  1‏
919 ‎‡a  catscratchesophagus‏ ‎‡A  Cat scratch esophagus‏ ‎‡9  1‏
919 ‎‡a  autoimmunepancreatitisresponsetocorticoidstest‏ ‎‡A  [Autoimmune pancreatitis: response to corticoids test]‏ ‎‡9  1‏
919 ‎‡a  atmosphericpressuredoesnotinfluenceacutediverticulardisease‏ ‎‡A  Atmospheric pressure does not influence acute diverticular disease‏ ‎‡9  1‏
919 ‎‡a  ascorbatedependentdecreaseofthemucosalimmuneinflammatoryresponsetogliadinincoeliacdiseasepatients‏ ‎‡A  Ascorbate-dependent decrease of the mucosal immune inflammatory response to gliadin in coeliac disease patients.‏ ‎‡9  1‏
919 ‎‡a  areworriesandconcernsinformationsideeffects‏ ‎‡A  Are Worries and Concerns Information Side Effects?‏ ‎‡9  1‏
919 ‎‡a  approachtothepathogenesisandtreatmentofnonalcoholicsteatohepatitis‏ ‎‡A  Approach to the pathogenesis and treatment of nonalcoholic steatohepatitis‏ ‎‡9  1‏
919 ‎‡a  antralvascularectasiaetiopathogenicclinicalandtherapeuticaspects‏ ‎‡A  [Antral vascular ectasia: etiopathogenic, clinical, and therapeutic aspects]‏ ‎‡9  1‏
919 ‎‡a  anothermultiplegastricanisakiasiscase‏ ‎‡A  Another multiple gastric anisakiasis case‏ ‎‡9  1‏
919 ‎‡a  annularpancreasapotentiallyoverlookedcongenitalpancreaticanomaly‏ ‎‡A  [Annular pancreas: a potentially overlooked congenital pancreatic anomaly]‏ ‎‡9  1‏
919 ‎‡a  unexpectedfindingofcatscratchcoloninascreeningcolonoscopy‏ ‎‡A  An unexpected finding of cat scratch colon in a screening colonoscopy‏ ‎‡9  1‏
919 ‎‡a  amebiasisandintestinalinflammatorydisease‏ ‎‡A  [Amebiasis and intestinal inflammatory disease]‏ ‎‡9  1‏
919 ‎‡a  alteredhumangutdendriticcellpropertiesinulcerativecolitisarereversedbylactobacillusplantarumextracellularencryptedpeptidestp‏ ‎‡A  Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp.‏ ‎‡9  1‏
919 ‎‡a  adalimumaborinfliximabforthepreventionofearlypostoperativerecurrenceofcrohndiseaseresultsfromtheeneidaregistry‏ ‎‡A  Adalimumab or Infliximab for the Prevention of Early Postoperative Recurrence of Crohn Disease: Results From the ENEIDA Registry‏ ‎‡9  1‏
919 ‎‡a  acuteesophagealnecrosisresolvedin72hours‏ ‎‡A  Acute esophageal necrosis resolved in 72 hours.‏ ‎‡9  1‏
919 ‎‡a  accuracyofureabreathtestperformedimmediatelyafteremergencyendoscopyinpepticulcerbleeding‏ ‎‡A  Accuracy of Urea Breath Test Performed Immediately After Emergency Endoscopy in Peptic Ulcer Bleeding‏ ‎‡9  1‏
919 ‎‡a  abdominalmassmultiplelymphadenopathiesandpolyposis‏ ‎‡A  Abdominal mass, multiple lymphadenopathies, and polyposis‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  ISNI|0000000139600415
996 ‎‡2  LC|no2005026470
996 ‎‡2  DNB|114507734X
996 ‎‡2  ISNI|0000000021846444
996 ‎‡2  BNC|981058521051306706
996 ‎‡2  SUDOC|178768014
996 ‎‡2  DNB|1056385707
996 ‎‡2  PTBNP|1771617
996 ‎‡2  DNB|1305606434
996 ‎‡2  LC|no2006024640
996 ‎‡2  SUDOC|241094852
996 ‎‡2  ISNI|0000000048419565
996 ‎‡2  NII|DA08945637
996 ‎‡2  BNE|XX1018468
996 ‎‡2  LC|no 97045830
996 ‎‡2  DNB|1057173274
996 ‎‡2  ISNI|0000000080160696
996 ‎‡2  LC|n 92112892
996 ‎‡2  RERO|A012099633
996 ‎‡2  ISNI|0000000386856071
996 ‎‡2  PTBNP|163017
996 ‎‡2  RERO|A028350588
996 ‎‡2  BNE|XX5474813
996 ‎‡2  ISNI|0000000045624467
996 ‎‡2  BNC|981060980793406706
996 ‎‡2  NTA|142301302
996 ‎‡2  LC|n 2010015273
996 ‎‡2  PLWABN|9811788760805606
996 ‎‡2  BNF|12413608
996 ‎‡2  NTA|072296917
996 ‎‡2  J9U|987007448923905171
996 ‎‡2  DNB|1056225696
996 ‎‡2  BIBSYS|10028012
996 ‎‡2  BNCHL|10000000000000000204012
996 ‎‡2  PLWABN|9810571355305606
996 ‎‡2  BNE|XX1149363
996 ‎‡2  PLWABN|9812399816705606
996 ‎‡2  LC|n 84114075
996 ‎‡2  ISNI|0000000023142854
996 ‎‡2  BNF|12129542
996 ‎‡2  DNB|1056649771
996 ‎‡2  CAOONL|ncf10725572
996 ‎‡2  LC|no2019188229
996 ‎‡2  BNE|XX1699775
996 ‎‡2  LC|no2016169308
996 ‎‡2  RERO|A017693982
996 ‎‡2  DNB|1056270403
996 ‎‡2  ISNI|0000000497844356
996 ‎‡2  SUDOC|135346711
996 ‎‡2  PTBNP|986672
996 ‎‡2  BNCHL|10000000000000000135624
996 ‎‡2  ISNI|0000000042723400
996 ‎‡2  ISNI|0000000021565175
996 ‎‡2  NII|DA15573714
996 ‎‡2  RERO|A013302955
996 ‎‡2  LC|no2009133173
996 ‎‡2  LC|n 00098658
996 ‎‡2  BNE|XX1365579
996 ‎‡2  SUDOC|030811007
996 ‎‡2  ISNI|0000000059873376
996 ‎‡2  ISNI|000000003499119X
996 ‎‡2  BNCHL|10000000000000000168865
996 ‎‡2  SUDOC|172176522
996 ‎‡2  ISNI|0000000076888502
996 ‎‡2  ISNI|0000000033830503
996 ‎‡2  LC|no2003109886
996 ‎‡2  DNB|1056496630
996 ‎‡2  SUDOC|05577637X
996 ‎‡2  BNE|XX1232231
996 ‎‡2  CAOONL|ncf11318326
996 ‎‡2  BNE|XX1050920
996 ‎‡2  RERO|A025316810
996 ‎‡2  LC|nr 99022690
996 ‎‡2  J9U|987007420312205171
996 ‎‡2  CAOONL|ncf12029143
996 ‎‡2  SUDOC|150347405
996 ‎‡2  ISNI|000000008126848X
996 ‎‡2  ISNI|0000000029248780
996 ‎‡2  BNCHL|10000000000000000127026
996 ‎‡2  BNF|17704292
996 ‎‡2  NUKAT|n 2021141457
996 ‎‡2  NTA|131291416
996 ‎‡2  DNB|1216526745
996 ‎‡2  BNE|XX6134235
996 ‎‡2  LC|no2008184849
996 ‎‡2  SUDOC|130061972
996 ‎‡2  LC|n 98031003
996 ‎‡2  NII|DA14779077
996 ‎‡2  BNCHL|10000000000000000852294
996 ‎‡2  LC|no2013051083
996 ‎‡2  BIBSYS|98055433
996 ‎‡2  ISNI|0000000054738570
996 ‎‡2  BIBSYS|90667717
996 ‎‡2  BNC|981058514509906706
996 ‎‡2  BNE|XX923636
996 ‎‡2  DNB|1189183013
996 ‎‡2  LC|n 2024183614
996 ‎‡2  LC|no2023000587
996 ‎‡2  LC|n 81115142
996 ‎‡2  NUKAT|n 2011104705
996 ‎‡2  SUDOC|075243474
996 ‎‡2  LC|n 2011077526
996 ‎‡2  BNE|XX876200
996 ‎‡2  BAV|495_133974
996 ‎‡2  BNCHL|10000000000000000083070
996 ‎‡2  RERO|A026009037
996 ‎‡2  DNB|13899613X
996 ‎‡2  DNB|1057042412
996 ‎‡2  BNF|12215115
996 ‎‡2  LC|no2004115498
996 ‎‡2  DNB|111520534X
996 ‎‡2  LC|no2018055706
996 ‎‡2  SUDOC|167255355
996 ‎‡2  LC|nr 98033670
996 ‎‡2  ISNI|0000000047060108
996 ‎‡2  DNB|131567291X
996 ‎‡2  SUDOC|134486684
996 ‎‡2  DNB|1056193034
996 ‎‡2  DNB|1222683377
996 ‎‡2  LC|no 95045197
996 ‎‡2  BNF|17012534
996 ‎‡2  CAOONL|ncf10693371
996 ‎‡2  ISNI|0000000067858432
996 ‎‡2  PLWABN|9812829927305606
996 ‎‡2  DNB|1157210597
996 ‎‡2  LC|nr 94024631
996 ‎‡2  LC|no2017136996
996 ‎‡2  LC|no2019044269
996 ‎‡2  LC|no2002071074
996 ‎‡2  ISNI|000000004892289X
996 ‎‡2  BNE|XX1133836
996 ‎‡2  BNC|981058517501406706
996 ‎‡2  LC|n 2013025385
996 ‎‡2  SUDOC|236847473
996 ‎‡2  LC|no2009005020
996 ‎‡2  BNCHL|10000000000000000042974
996 ‎‡2  SUDOC|18866579X
996 ‎‡2  LC|n 97078063
996 ‎‡2  LC|n 80006513
996 ‎‡2  ISNI|0000000498698805
996 ‎‡2  LC|no2009134617
996 ‎‡2  LC|ns2013002749
996 ‎‡2  DNB|133220001
996 ‎‡2  ISNI|0000000081883220
996 ‎‡2  SUDOC|253497043
996 ‎‡2  LC|no2014021092
996 ‎‡2  BNE|XX879919
996 ‎‡2  DNB|1333564422
996 ‎‡2  SELIBR|317414
996 ‎‡2  NTA|264788753
996 ‎‡2  J9U|987007383998905171
996 ‎‡2  LC|n 81050602
996 ‎‡2  PTBNP|1803777
996 ‎‡2  LC|no2003122450
996 ‎‡2  DNB|1057229555
996 ‎‡2  DNB|129563757
996 ‎‡2  LC|n 2004099466
996 ‎‡2  SUDOC|140230025
996 ‎‡2  DNB|140752226
996 ‎‡2  LC|n 2019034159
996 ‎‡2  LC|no2022080642
996 ‎‡2  LC|ns2018000357
996 ‎‡2  PTBNP|1807705
996 ‎‡2  BNF|14577722
996 ‎‡2  J9U|987007432844405171
996 ‎‡2  BNC|981059289071206706
996 ‎‡2  NTA|419274839
996 ‎‡2  DNB|1056292555
996 ‎‡2  BNE|XX1269475
996 ‎‡2  DNB|1056258497
996 ‎‡2  LC|n 2017017952
996 ‎‡2  LC|no2006048920
996 ‎‡2  ISNI|0000000049524420
996 ‎‡2  LC|nr 96025184
996 ‎‡2  BNCHL|10000000000000000171817
996 ‎‡2  LC|n 90715543
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏